Starr, Tyler N. http://orcid.org/0000-0001-6713-6904
Czudnochowski, Nadine
Liu, Zhuoming http://orcid.org/0000-0001-8198-0976
Zatta, Fabrizia
Park, Young-Jun http://orcid.org/0000-0003-2901-6949
Addetia, Amin
Pinto, Dora
Beltramello, Martina
Hernandez, Patrick http://orcid.org/0000-0001-9704-5093
Greaney, Allison J.
Marzi, Roberta http://orcid.org/0000-0001-6025-6735
Glass, William G.
Zhang, Ivy
Dingens, Adam S. http://orcid.org/0000-0001-9603-9409
Bowen, John E. http://orcid.org/0000-0003-3590-9727
Tortorici, M. Alejandra http://orcid.org/0000-0002-2260-2577
Walls, Alexandra C. http://orcid.org/0000-0002-9636-8330
Wojcechowskyj, Jason A.
De Marco, Anna
Rosen, Laura E. http://orcid.org/0000-0002-8030-0219
Zhou, Jiayi http://orcid.org/0000-0002-4231-3422
Montiel-Ruiz, Martin http://orcid.org/0000-0001-6200-9578
Kaiser, Hannah http://orcid.org/0000-0002-3991-7401
Dillen, Josh R.
Tucker, Heather
Bassi, Jessica
Silacci-Fregni, Chiara
Housley, Michael P.
di Iulio, Julia
Lombardo, Gloria
Agostini, Maria
Sprugasci, Nicole
Culap, Katja http://orcid.org/0000-0002-0956-0018
Jaconi, Stefano http://orcid.org/0000-0001-7527-4434
Meury, Marcel
Dellota Jr, Exequiel
Abdelnabi, Rana
Foo, Shi-Yan Caroline http://orcid.org/0000-0002-6380-4917
Cameroni, Elisabetta
Stumpf, Spencer
Croll, Tristan I.
Nix, Jay C. http://orcid.org/0000-0002-4041-4975
Havenar-Daughton, Colin http://orcid.org/0000-0002-2880-3927
Piccoli, Luca http://orcid.org/0000-0002-1085-6502
Benigni, Fabio
Neyts, Johan http://orcid.org/0000-0002-0033-7514
Telenti, Amalio http://orcid.org/0000-0001-6290-7677
Lempp, Florian A. http://orcid.org/0000-0001-6103-8078
Pizzuto, Matteo S. http://orcid.org/0000-0001-5776-654X
Chodera, John D. http://orcid.org/0000-0003-0542-119X
Hebner, Christy M.
Virgin, Herbert W. http://orcid.org/0000-0001-8580-7628
Whelan, Sean P. J.
Veesler, David http://orcid.org/0000-0002-6019-8675
Corti, Davide http://orcid.org/0000-0002-5797-1364
Bloom, Jesse D. http://orcid.org/0000-0003-1267-3408
Snell, Gyorgy http://orcid.org/0000-0003-1475-659X
Article History
Received: 29 March 2021
Accepted: 6 July 2021
First Online: 14 July 2021
Competing interests
: N.C., F.Z., D.P., M.B., P.H., R.M., J.A.W., A.D.M., L.E.R., J.Z., M.M.-R., H.K., J.R.D., H.T., J.B., C.S.-F., M.P.H., J.d.I., G.L., M.A., N.S., K.C., S.J., M.M., E.D.Jr, E.C., C.H.-D., L.P., F.B., A.T., F.A.L., M.S.P., C.M.H., H.W.V., D.C. and G.S. are or were employees of Vir Biotechnology and may hold shares in Vir Biotechnology. D.C. is currently listed as an inventor on multiple patent applications, which disclose the subject matter described in this manuscript. After the submission of the initial version of this study, J.D.B. began consulting for Moderna on viral evolution and epidemiology. J.D.B. has the potential to receive a share of IP revenue as an inventor on a Fred Hutchinson Cancer Research Center-optioned technology/patent (application WO2020006494) related to deep mutational scanning of viral proteins. H.W.V. is a founder of PierianDx and Casma Therapeutics. Neither company provided funding for this work nor is performing related work. J.C.N., T.I.C. and D.V. are consultants for Vir Biotechnology Inc. The Veesler laboratory has received a sponsored research agreement from Vir Biotechnology Inc. J.D.C. is a current member of the Scientific Advisory Boards of OpenEye Scientific Software, Interline Therapeutics, and Redesign Science. The Chodera laboratory receives or has received funding from the National Institute of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biotechnology, XtalPi, Interline Therapeutics, and the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, and the Sloan Kettering Institute. A complete funding history for the Chodera lab can be found at ExternalRef removed. The other authors declare no competing interests.
Free to read: This content has been made available to all.